GSTM1 and sickle cell disease: CA is a standard clinical feature seen in patients with hemoglobinopathies (6), mainly represented by qualitative disorders in Hb structure (e.g., sickle cell disease, SCD) and quantitative disorders of Hb synthesis (e.g., thalassemia syndromes, non-SCD) (7).